About Heart-Lung Machines
The Expanding Pervasiveness for Heart Sicknesses, Rising awareness about the Distinctive Cardiovascular Devices, accessible and Developing Government activities are driving the Global Heart-Lung Machine (HLM) Market. HLM is also Known as Oxygenator Pump Or Cardiopulmonary Bypass (CPB) Pump. It aims to Provide extracorporeal Circulation (ECC) with the maintenance of Oxygenated Blood Flow to the Body Organs When the Device is Connected to the arteriovenous System. The HLM, for the most part, incorporates a Chamber that gathers the blood from the Body & additionally Oxygenates it, Lastly Exchanges it to various parts of the Body. This Equipment is Connected to the Patient with a Scope of Tubes, which is Isolated after the Finish of the task when the Lungs and Heart retain its Capacities.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
CAGR | 3.67% |
There is a presence Global players who are offering a wide variety of Heart-Lung Machines in the Market, hence the level of competition is highly intense.The players of the developed markets are focusing on product innovations and extensions of their product line as it will help them to bolster their hold over the market.Vendors like LivaNova have started to penetrate the market in APAC to increase their market shares.The Players having a strong hold in the market are LivaNova. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Heart-Lung Machines market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Medtronic PLC (Ireland), MAQUET Holding B.V. & Co. KG (Germany), Terumo Medical Corporation (Japan), Edwards Lifesciences (United States), Braile Biomedica (Brazil), Tianjin Medical Group Co. Ltd. (China), RZ Medizintechnik GmbH (Germany) and SynCardia Systems LLC (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Jarvik Heart Inc. (United States) and LivaNova PLC (United Kingdom).
Segmentation Overview
AMA Research has segmented the market of Global Heart-Lung Machines market by Type (Single Roller Pump and Double Roller Pump), Application (Cardiac Surgery, Lung Transplantation Operations, Acute Respiratory Failure Treatment and Others) and Region.
On the basis of geography, the market of Heart-Lung Machines has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. If we see Market by End user, the sub-segment i.e. Hospitals will boost the Heart-Lung Machines market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
The advent of Portable Heart-Lung Machines as these machines are being used by the Hospitals due to its Less weight and it Occupies Less Space in the Operating Rooms, unlike Conventional Heart-Lung Machines., These Machines Can Be Operated On a Rechargeable Battery and can be Transported to any Part of the Hospital. and Development of Miniatured HLM.
Market Growth Drivers:
The High Prevalence of Cardiovascular Diseases among Patients Leading To Increased Cardiac Surgeries, Changing Lifestyle in Emerging Economies, Increase in medical tourism as Complications associated with CABG surgeries, High cost of heart-lung machine in APAC countries and Bypass surgery, Availability of minimally and less invasive procedures and The Growing Need for Improved Healthcare & Affordable Healthcare Services.
Challenges:
Complications associated with Coronary artery bypass grafting (CABG) surgeries and Availability of minimally and less invasive procedures in the medical sector.
Restraints:
Lack of skilled medical professional for properly operating the device & Less life cycle of the product and The high cost of the heart-lung machine and bypass surgery may hinder the growth of the market.
Opportunities:
Technological advancements and improvement in healthcare facilities is providing an opportunity for the market players to innovate more sophisticated HLMs like Extracorporeal Membrane Oxygenation (ECMO) Device.
Market Leaders and their expansionary development strategies
In March 2019, The LivaNova launched VITARIA System which delivers Autonomic Regulation Therapy (ART) using Vagus Nerve Stimulation (VNS) to treat patients with chronic, symptomatic Heart failure with Reduced Ejection Fraction (HFrEF). VITARIA is currently being used to study the effects of ART in a prospective, international, randomized, controlled clinical trial.
In March 2023, UK-based LivaNova said it received 510(k) clearance from the U.S. Food and Drug Administration for its Essenz Heart-Lung Machine, which is paired with LivaNova’s patient monitor to create a perfusion system used during cardiopulmonary bypass procedures. A perfusion system acts as a patient’s heart and lungs during an open-heart procedure.
Key Target Audience
Heart Lung Machine Manufacturers, Traders/Distributors/Suppliers, Government & Regulatory Agencies, Potential Investors, Health care facilities and Downstream Vendors
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.